Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof
US-12187684-B2 · Jan 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Zhang Minsheng patents
Zhang Minsheng is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Zhang Minsheng |
| Total patents | 8 |
| First publication | Apr 24, 2018 |
| Latest publication | Jan 7, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORy) and Pharmaceutical Use Thereof
US-2023130361-A1 · Apr 27, 2023 · US
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof
US-11512055-B2 · Nov 29, 2022 · US
Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORy) and Pharmaceutical Uses Thereof
US-2021171471-A1 · Jun 10, 2021 · US
Aminopyridazinone compounds as protein kinase inhibitors
US-10323037-B2 · Jun 18, 2019 · US
Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors
US-10144737-B2 · Dec 4, 2018 · US
Aminopyridazinone compounds as protein kinase inhibitors
US-2018251465-A1 · Sep 6, 2018 · US
Aminopyridazinone compounds as protein kinase inhibitors
US-9951077-B2 · Apr 24, 2018 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Jiangsu Hengrui Medicine Co | 8 |
| Shanghai hengrui pharmaceutical co ltd | 4 |
| Eternity Bioscience Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P37/00 | 8 |
| A61P35/00 | 8 |
| C07D487/04 | 4 |
| C07D211/38 | 4 |
| A61P29/00 | 4 |